​​

Arterna Biosciences was founded in Reykjavik, Iceland, in the autumn 2021. Our founders bring different expertise to the clear goal of Arterna to improve the quality of mRNA.

 

With the initial focus on RNA polymerases, we have developed the proprietary ArtPure™ purification platform. Using this platform we offer a range of highly pure RNA polymerases, yielding high quality mRNA.

​

​

​

 

Our development program is yielding novel RNA polymerases and other novel components into the mRNA reaction. We welcome all collaboration and would love to be in contact on your needs regarding IVT requirements.

​

We believe that innovation with focus on quality in mRNA production is key to the success of the mRNA medicine revolution.